These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 36613623
1. Distinct Effects of Beta-Amyloid, Its Isomerized and Phosphorylated Forms on the Redox Status and Mitochondrial Functioning of the Blood-Brain Barrier Endothelium. Petrovskaya AV, Tverskoi AM, Barykin EP, Varshavskaya KB, Dalina AA, Mitkevich VA, Makarov AA, Petrushanko IY. Int J Mol Sci; 2022 Dec 22; 24(1):. PubMed ID: 36613623 [Abstract] [Full Text] [Related]
2. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium. Wang Z, Sharda N, Omtri RS, Li L, Kandimalla KK. Mol Pharmacol; 2023 Nov 22; 104(5):203-213. PubMed ID: 37541759 [Abstract] [Full Text] [Related]
3. Post-translational modifications of beta-amyloid alter its transport in the blood-brain barrier in vitro model. Varshavskaya KB, Petrushanko IY, Mitkevich VA, Barykin EP, Makarov AA. Front Mol Neurosci; 2024 Nov 22; 17():1362581. PubMed ID: 38516041 [Abstract] [Full Text] [Related]
4. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-β 40 and 42 at the Blood-Brain Barrier Endothelium. Sharda N, Ahlschwede KM, Curran GL, Lowe VJ, Kandimalla KK. J Pharmacol Exp Ther; 2021 Mar 22; 376(3):482-490. PubMed ID: 33303699 [Abstract] [Full Text] [Related]
5. A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model. Acharya NK, Grossman HC, Clifford PM, Levin EC, Light KR, Choi H, Swanson Ii RL, Kosciuk MC, Venkataraman V, Libon DJ, Matzel LD, Nagele RG. J Alzheimers Dis; 2024 Mar 22; 98(1):163-186. PubMed ID: 38393907 [Abstract] [Full Text] [Related]
6. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding. Shackleton B, Crawford F, Bachmeier C. Fluids Barriers CNS; 2016 Aug 08; 13(1):14. PubMed ID: 27503326 [Abstract] [Full Text] [Related]
9. Blood-Brain Barrier Permeable Chitosan Oligosaccharides Interfere with β-Amyloid Aggregation and Alleviate β-Amyloid Protein Mediated Neurotoxicity and Neuroinflammation in a Dose- and Degree of Polymerization-Dependent Manner. Zhu L, Li R, Jiao S, Wei J, Yan Y, Wang ZA, Li J, Du Y. Mar Drugs; 2020 Sep 25; 18(10):. PubMed ID: 32992800 [Abstract] [Full Text] [Related]
10. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-β Distribution between Brain and Plasma. Swaminathan SK, Zhou AL, Ahlschwede KM, Curran GL, Lowe VJ, Li L, Kandimalla KK. J Pharmacol Exp Ther; 2020 Nov 25; 375(2):308-316. PubMed ID: 32778535 [Abstract] [Full Text] [Related]
11. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis. Parodi-Rullán R, Ghiso J, Cabrera E, Rostagno A, Fossati S. Aging Cell; 2020 Nov 25; 19(11):e13258. PubMed ID: 33155752 [Abstract] [Full Text] [Related]
12. Annexin A1 restores Aβ1-42 -induced blood-brain barrier disruption through the inhibition of RhoA-ROCK signaling pathway. Park JC, Baik SH, Han SH, Cho HJ, Choi H, Kim HJ, Choi H, Lee W, Kim DK, Mook-Jung I. Aging Cell; 2017 Feb 25; 16(1):149-161. PubMed ID: 27633771 [Abstract] [Full Text] [Related]
13. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature. Agyare EK, Leonard SR, Curran GL, Yu CC, Lowe VJ, Paravastu AK, Poduslo JF, Kandimalla KK. Mol Pharm; 2013 May 06; 10(5):1557-65. PubMed ID: 23249146 [Abstract] [Full Text] [Related]
14. Insulin Signaling Differentially Regulates the Trafficking of Insulin and Amyloid Beta Peptides at the Blood-Brain Barrier. Zhou AL, Swaminathan SK, Salian VS, Wang L, Curran GL, Min HK, Lowe VJ, Kandimalla KK. Mol Pharm; 2024 May 06; 21(5):2176-2186. PubMed ID: 38625027 [Abstract] [Full Text] [Related]
15. Docking and Molecular Dynamics-Based Identification of Interaction between Various Beta-Amyloid Isoforms and RAGE Receptor. Tolstova AP, Adzhubei AA, Mitkevich VA, Petrushanko IY, Makarov AA. Int J Mol Sci; 2022 Oct 05; 23(19):. PubMed ID: 36233130 [Abstract] [Full Text] [Related]
16. Effect of High Cholesterol Regulation of LRP1 and RAGE on Aβ Transport Across the Blood-Brain Barrier in Alzheimer's Disease. Zhou R, Chen LL, Yang H, Li L, Liu J, Chen L, Hong WJ, Wang CG, Ma JJ, Huang J, Zhou XF, Liu D, Zhou HD. Curr Alzheimer Res; 2021 Oct 05; 18(5):428-442. PubMed ID: 34488598 [Abstract] [Full Text] [Related]
17. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain. Rofo F, Ugur Yilmaz C, Metzendorf N, Gustavsson T, Beretta C, Erlandsson A, Sehlin D, Syvänen S, Nilsson P, Hultqvist G. Theranostics; 2021 Oct 05; 11(2):789-804. PubMed ID: 33391505 [Abstract] [Full Text] [Related]
18. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling. Qosa H, Abuasal BS, Romero IA, Weksler B, Couraud PO, Keller JN, Kaddoumi A. Neuropharmacology; 2014 Apr 05; 79():668-78. PubMed ID: 24467845 [Abstract] [Full Text] [Related]
19. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides. Xiong H, Callaghan D, Jones A, Bai J, Rasquinha I, Smith C, Pei K, Walker D, Lue LF, Stanimirovic D, Zhang W. J Neurosci; 2009 Apr 29; 29(17):5463-75. PubMed ID: 19403814 [Abstract] [Full Text] [Related]